Induction of
tumor vascular normalization is a crucial measure to enhance
immunotherapy efficacy. cGAS-
STING pathway is vital for anti-
tumor immunity, but its role in
tumor vasculature is unclear. Herein, using preclinical
liver cancer models in Cgas/
Sting-deficient male mice, we report that the interdependence between
tumor cGAS and host
STING mediates vascular normalization and anti-
tumor immune response. Mechanistically, TET2 mediated IL-2/STAT5A signaling epigenetically upregulates
tumor cGAS expression and produces
cGAMP. Subsequently,
cGAMP is transported via LRRC8C channels to activate
STING in endothelial cells, enhancing recruitment and transendothelial migration of lymphocytes. In vivo studies in male mice also reveal that administration of
vitamin C, a promising anti-
cancer agent, stimulates TET2 activity, induces
tumor vascular normalization and enhances the efficacy of anti-PD-L1
therapy alone or in combination with
IL-2. Our findings elucidate a crosstalk between
tumor and vascular endothelial cells in the
tumor immune microenvironment, providing strategies to enhance the efficacy of combinational
immunotherapy for
liver cancer.